Back to search
Advanced Relapsed or Refractory Germ Cell Tumours
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Relapsed or Refractory Germ Cell Tumours trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Relapsed or Refractory Germ Cell Tumours trials you may qualify forResearchers are looking for new ways to treat children with different types of melanoma (skin cancer), solid tumors, and lymphomas (blood cancers) that are any…
This study is open to adults with advanced germ cell tumours, endometrial cancer, or ovarian cancer whose previous treatments were not successful. People can jo…
This Phase 1/2 study evaluates the safety, feasibility, and preliminary anti-tumor activity of allogeneic donor-derived CAR-NK cells in participants with advanc…
This phase II Pediatric MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in pediatric patients with soli…
The goal of this clinical trial is to learn about the effectiveness and safety of the bispecific antibody acasunlimab (also known as DuoBody®-PD-L1x4-1BB) when…